TY - JOUR
T1 - Dysphonia and dyspnea in idiopathic hypereosinophilic syndrome treated with Mepolizumab
AU - Kay, Dana
AU - Ataya, Ali
AU - Liu, Xiuli
AU - Auerbach, Jena
AU - Urbine, Dan
N1 - Publisher Copyright:
© 2018 The Authors
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Hypereosinophilic syndrome (HES) is characterized by a persistently elevated eosinophil count associated with eosinophil-related end-organ damage and thromboembolic events, in the absence of an identifiable cause. We present a case of idiopathic HES with evidence of peripheral and tissue eosinophilia while on high dose prednisone, associated with muscle tension dysphonia, colitis, and jackhammer esophagus. The patient was treated with the interleukin-5 inhibitor, Mepolizumab, with resolution of symptoms including dyspnea, diarrhea and dysphonia.
AB - Hypereosinophilic syndrome (HES) is characterized by a persistently elevated eosinophil count associated with eosinophil-related end-organ damage and thromboembolic events, in the absence of an identifiable cause. We present a case of idiopathic HES with evidence of peripheral and tissue eosinophilia while on high dose prednisone, associated with muscle tension dysphonia, colitis, and jackhammer esophagus. The patient was treated with the interleukin-5 inhibitor, Mepolizumab, with resolution of symptoms including dyspnea, diarrhea and dysphonia.
UR - http://www.scopus.com/inward/record.url?scp=85048272458&partnerID=8YFLogxK
U2 - 10.1016/j.rmcr.2018.05.013
DO - 10.1016/j.rmcr.2018.05.013
M3 - Article
AN - SCOPUS:85048272458
SN - 2213-0071
VL - 25
SP - 30
EP - 32
JO - Respiratory Medicine Case Reports
JF - Respiratory Medicine Case Reports
ER -